Charkaluk, Marie-Laure http://orcid.org/0000-0002-6972-3608
Rousseau, Jessica
Dehouck-Vallois, Marine
Jarreau, Pierre-Henri
Nuytten, Alexandra
Treluyer, Ludovic
Ancel, Pierre-YvesY
Torchin, Héloïse
Funding for this research was provided by:
French Equipex Program of Investments in the Future (ANR-11-AQPX-0038)
Article History
Received: 20 November 2020
Revised: 15 January 2021
Accepted: 18 January 2021
First Online: 1 February 2021
Declarations
:
: AbbVie France, Inc. contributed to the funding of analyses concerning palivizumab in Epipage-2. They played no role in the study design, collection, analysis, or interpretation of data, writing of the manuscript, or decision to submit the manuscript for publication. PH Jarreau is a member of the neonatal board of AbbVie France, Inc. None of the authors perceived any form of payment to produce the manuscript.